Oncotelic Therapeutics, Inc. (OTCMKTS:OTLC – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 2,400 shares, a growth of 500.0% from the May 15th total of 400 shares. Based on an average trading volume of 242,700 shares, the short-interest ratio […]
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
ONCOTELIC TO PARTICIPATE AT THE BIO INTERNATIONAL 2024 MEETING tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
AGOURA HILLS, Calif., May 20, 2024 Oncotelic Therapeutics, Inc announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting. Abstract: e16318..
Contrasting Oncotelic Therapeutics (OTCMKTS:OTLC) and Entrada Therapeutics (NASDAQ:TRDA) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.